Condition
Post-COVID Conditions
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07359482Phase 3Not Yet Recruiting
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
NCT05880108Not ApplicableRecruitingPrimary
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
NCT06784713Completed
DIFFERENT SARS-COV-2 VARIANTS' EFFECT ON THE COURSE OF COVID-19 IN ESTONIAN CHILDREN
NCT05758649CompletedPrimary
Cardiovascular and Psychological Consequences of COVID-19
Showing all 4 trials